Active	Status	Sponsor type	Region	Phase	Filter
45 Active 35 Inactive 80 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Trivedi, Madhukar
NCT05711940: Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD	Recruiting	3	568	Europe, Canada, US, RoW	Psilocybin, COMP360	COMPASS Pathways	Treatment Resistant Depression	03/25	05/25
Shoptaw, Steven
NCT05017272: Technology for MAT in Primary Care - Phase 2	Enrolling by invitation	N/A	200	US	Opioid Addiction Recovery Support Software Platform, OARS	Q2i, LLC, University of California, Los Angeles, National Institute on Drug Abuse (NIDA)	Opioid-use Disorder	05/23	08/23
Hendricks, Peter S
NCT05227742: Exploratory Study of Low Dose Psilocybin	Recruiting	1	60	US	Psilocybin, Placebo	University of Alabama at Birmingham, Diamond Therapeutics Inc.	Demoralization	12/24	12/24
Hall, Timothy
SURPASS-EARLY, NCT05433584: A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes	Active, not recruiting	4	780	Europe, Canada, US, RoW	Tirzepatide, LY3298176, Antihyperglycemic medication	Eli Lilly and Company	Type 2 Diabetes	10/25	11/27
SURMOUNT-5, NCT05822830: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities	Completed	3	751	US	Tirzepatide, LY3298176, Semaglutide	Eli Lilly and Company	Obesity, Overweight	11/24	11/24
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity	Active, not recruiting	3	15374	Europe, Canada, Japan, US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Obesity, Overweight	10/27	10/27
Blades, Christopher
No trials found
Blair, Cherie
No trials found
Riley, Simone J
No trials found
Tavarez, Jasmin
No trials found